4.15

2.58% -0.11

Bionexus Gene Lab Corp (BGLC)

Overview News Price History Discussions Forecast

Bionexus Gene Lab Corp stock is traded at $4.15, with a volume of 26,763. It is down -2.58% in the last 24 hours and down -14.26% over the past month. BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Previous Close:

$4.26

Open:

$4.24

24h Volume:

26,763

Relative Volume:

0.15

Market Cap:

$9.81M

Revenue:

$9.26M

Net Income/Loss:

$-941.60K

P/E Ratio:

-57.64

EPS:

-0.072

Net Cash Flow:

$-2.65M

1W Performance:

+0.97%

1M Performance:

-14.26%

6M Performance:

+42.37%

1Y Performance:

+53.14%

1-Day Range:

$4.10

$4.24

1-Week Range:

$4.00

$4.34

52-Week Range:

$2.0068

$15.60

Bionexus Gene Lab Corp Stock (BGLC) Company Profile

Name

Bionexus Gene Lab Corp

Sector

Basic Materials (270)

Industry

Specialty Chemicals (61)

Phone

1-307-241-6898

Address

10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BGLC's Discussions on Twitter

Compare BGLC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BGLC BioNexus Gene Lab Corp Common stock	0.343	201.51M	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.66	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	4.30	268.44M	2.07B	-1.42B	-1.37B	-0.6765
SHMD Schmid Group N V	5.14	223.06M	0	0	0	0.00
DAVEW Dave Inc	0.7287	0	0	0	0	0.00
DWLD Davis Select Worldwide ETF	46.74	0	0	0	0	0.00

Bionexus Gene Lab Corp Stock (BGLC) Latest News

Dec 13, 2025

Analysis Recap: How BioNexus Gene Lab Corp stock valuations compare to rivalsStop Loss & Target Return Focused Stock Picks - moha.gov.vn

Dec 13, 2025

Dec 11, 2025

BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Nigeria

Dec 11, 2025

Dec 05, 2025

Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser

Dec 05, 2025

Dec 04, 2025

BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN

Dec 04, 2025

12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga

Dec 04, 2025

Dec 03, 2025

A Look at BioNexus Gene Lab Corp (BGLC) Shares in the Recent Past Indicates Growth - setenews.com

Dec 03, 2025

Blue Gold Sets $15 Million Gold Trading Facility - marketscreener.com

Dec 03, 2025

Bionexus Gene Lab completes strategic investment in Fidelion Diagnostics, secures 15% equity stake in global AI Oncologic platform - MarketScreener

Dec 03, 2025

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics - Investing.com

Dec 03, 2025

BioNexus Gene Lab Corp. Completes Strategic Transaction with Fidelion Diagnostics, Securing Exclusive Rights for VitaGuard™ in Southeast Asia - Quiver Quantitative

Dec 03, 2025

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard - marketscreener.com

Dec 03, 2025

BioNexus Gene Lab (NASDAQ: BGLC) acquires 15% Fidelion stake, VitaGuard ASEAN rights - Stock Titan

Dec 03, 2025

Dec 02, 2025

BioNexus Gene Lab secures $500 million equity purchase agreement By Investing.com - Investing.com Nigeria

Dec 02, 2025

BioNexus Gene Lab stock falls after securing $500M equity facility - Investing.com Nigeria

Dec 02, 2025

BioNexus Gene Lab stock falls after securing $500M equity facility By Investing.com - Investing.com South Africa

Dec 02, 2025

BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility - MSN

Dec 02, 2025

Bionexus Gene Lab secures $500M equity facility from ARC Group - TipRanks

Dec 02, 2025

BioNexus Gene Lab (BGLC) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

BioNexus Gene Lab secures $500 million equity purchase agreement - Investing.com

Dec 02, 2025

Bionexus Gene Lab Corp enters $500 million equity purchase agreement - marketscreener.com

Dec 02, 2025

BioNexus Gene Lab stock climbs after securing $500 million equity facility - Investing.com UK

Dec 02, 2025

BioNexus Gene Lab stock climbs after securing $500 million equity facility By Investing.com - Investing.com India

Dec 02, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization - The Manila Times

Dec 02, 2025

BioNexus Gene Lab (Nasdaq: BGLC) lines up $500M ARC equity facility for MRD, CDMO push - Stock Titan

Dec 02, 2025

Dec 01, 2025

Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform - TipRanks

Dec 01, 2025

Bionexus Gene Lab Corp to pay $2 million license fee to Fidelion - marketscreener.com

Dec 01, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene - The Manila Times

Dec 01, 2025

BioNexus Gene Lab (Nasdaq: BGLC) secures royalty-free VitaGuard MRD rights in SE Asia - Stock Titan

Dec 01, 2025

Nov 29, 2025

BioNexus Gene Lab Corp Stock Analysis and ForecastMarket Sentiment Shifts & Hedge Fund-Style Analysis Now Free - earlytimes.in

Nov 29, 2025

Nov 27, 2025

BioNexus Gene Lab Corp. announced that it expects to receive $500 million in funding from ARC Group International Ltd - marketscreener.com

Nov 27, 2025

Nov 26, 2025

Big Picture: How supply chain issues affect BioNexus Gene Lab Corp. stockWeekly Trade Summary & Low Risk High Reward Ideas - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

BioNexus Gene Lab files $100M shelf registration and establishes $20M at-the-market program - MSN

Nov 25, 2025

Nov 21, 2025

How interest rate cuts could boost BioNexus Gene Lab Corp. stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Will BioNexus Gene Lab Corp. stock outperform growth indexesDividend Hike & Real-Time Stock Entry Alerts - newser.com

Nov 20, 2025

Why BioNexus Gene Lab Corp. stock remains a top recommendation2025 Top Decliners & Proven Capital Preservation Methods - newser.com

Nov 20, 2025

Nov 19, 2025

Is BioNexus Gene Lab Corp. stock reversal real or fakeDay Trade & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025

Will BioNexus Gene Lab Corp. stock outperform Nasdaq indexQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com

Nov 19, 2025